Zobrazeno 1 - 10
of 1 350
pro vyhledávání: '"icatibant"'
Publikováno v:
Emergency Care Journal (2024)
A 91-year-old man presented at our emergency room complaining of sialorrhea and facial edema, especially around his lips and palpebral region. The symptoms started in the morning and got worse over two hours. He had a history of hypertension and hypo
Externí odkaz:
https://doaj.org/article/c601700d5fe146649351e8633b9f0f33
Autor:
Adil Adatia, MD, Bruce Ritchie, MD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 2, Pp 100087- (2023)
We report an approximately 80% reduction in angioedema attacks with lanadelumab, a mAb targeting plasma kallikrein, in a case of hereditary angioedema with normal C1 inhibitor levels. This finding supports a central pathophysiologic role for kallikre
Externí odkaz:
https://doaj.org/article/b94ec6de38514eb28c5232f351e72c21
Autor:
Mar Guilarte, Anna Sala-Cunill, María Luisa Baeza, Rosario Cabañas, María Dolores Hernández, Ethel Ibañez, Carlos Hernando de Larramendi, Ramon Lleonart, Teófilo Lobera, Luis Marqués, Blanca Sáenz de San Pedro, Jaco Botha, Irmgard Andresen, Teresa Caballero, for the IOS Study Group
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 17, Iss 1, Pp 1-11 (2021)
Abstract Background The Icatibant Outcome Survey (IOS) is an international registry monitoring the use of icatibant, a bradykinin B2 receptor antagonist indicated for the acute treatment of hereditary angioedema (HAE) attacks. Our goal was to assess
Externí odkaz:
https://doaj.org/article/90ff5c111ba24797ac5c9aba507fb7be
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Allergology International, Vol 70, Iss 1, Pp 45-54 (2021)
Hereditary angioedema (HAE) is characterized by unpredictable, recurring and painful swelling episodes that can be disabling or even life-threatening. Awareness of HAE has progressively grown worldwide, and options for treatment of acute attacks and
Externí odkaz:
https://doaj.org/article/7e3c036fe5d94d248253f94df68a9bc5
Autor:
Eli Mansour, Flávia F. Bueno, José C. de Lima-Júnior, Andre Palma, Milena Monfort-Pires, Bruna Bombassaro, Eliana P. Araujo, Ana Flavia Bernardes, Raisa G. Ulaf, Thyago A. Nunes, Luciana C. Ribeiro, Antônio Luís E. Falcão, Thiago Martins Santos, Plinio Trabasso, Rachel P. Dertkigil, Sergio S. Dertkigil, Rafael P. Maia, Tatiana Benaglia, Maria Luiza Moretti, Licio A. Velloso
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background SARS-CoV-2, the virus that causes COVID-19, enters the cells through a mechanism dependent on its binding to angiotensin-converting enzyme 2 (ACE2), a protein highly expressed in the lungs. The putative viral-induced inhibition of
Externí odkaz:
https://doaj.org/article/2949959a2f74456b8f93ce0e80a8d848
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-11 (2020)
Abstract Background This is a retrospective review of the Winnipeg Regional Health Authority’s (WRHA) angioedema patients who were dispensed icatibant in hospital. Icatibant is a bradykinin B2 receptor antagonist indicated for Hereditary Angioedema
Externí odkaz:
https://doaj.org/article/833fa9bbbebb441dae0e79e78298dc88
Autor:
Roman Nowicki, Elżbieta Grubska-Suchanek, Grzegorz Porębski, Marek L. Kowalski, Karina Jahnz-Różyk, Tomasz Matuszewski, Lidia Rudnicka, Marek Kulus, Wioletta Barańska-Rybak, Rafał Czajkowski, Zbigniew Doniec, Cezary Kowalewski, Beata Kręcisz, Magdalena Lange, Joanna Narbutt, Małgorzata Olszewska, Małgorzata Sokołowska-Wojdyło, Aneta Szczerkowska-Dobosz, Radosław Śpiewak, Magdalena Trzeciak, Aleksandra Wilkowska
Publikováno v:
Przegląd Dermatologiczny, Vol 107, Iss 4, Pp 293-307 (2020)
Angioedema is a non-inflammatory edema of the subcutaneous tissue and/or mucosal membranes. It commonly coexists with urticaria and is considered a deep form of urticaria. Less commonly, it occurs as an isolated disease in one of two basic forms: acq
Externí odkaz:
https://doaj.org/article/bd5150961a7f4f229e027dfc1e81e80e
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-10 (2020)
Abstract Background Hereditary angioedema (HAE) in patients with normal C1 inhibitor (C1-INH) and the c.988A > G (p.Lys330Glu; p.K330E) variant in the plasminogen gene (HAE-PLG) is associated with skin swellings, abdominal pain attacks, and the risk
Externí odkaz:
https://doaj.org/article/78003f8c78684689aca71e67ded4e00c
Autor:
Douglas H. Jones, MD, Priya Bansal, MD, Jonathan A. Bernstein, MD, Shahnaz Fatteh, MD, Joseph Harper, PharmD, F. Ida Hsu, MD, Maeve O’Connor, MD, Nami Park, PharmD, Daniel Suez, MD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 1, Pp 100621- (2022)
Background: Hereditary angioedema (HAE) is often caused by low serum levels or functional deficiency in C1 inhibitor (C1-INH); however, in some cases, C1-INH serum level and function are measured as normal (HAE-nl-C1INH). Management of HAE-nl-C1INH i
Externí odkaz:
https://doaj.org/article/532c5bdec9a240c88b9e8106405ecd30